A meta analysis on risks of adverse pregnancy outcomes in Toxoplasma gondii infection

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Li, Xue Lan ^a   Wei, Hai Xia ^a   Zhang, Hao ^a   Peng, Hong Juan ^a   Lindsay, David S ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLINIC ACID; PYRIMETHAMINE; SPIRAMYCIN; SULFADIAZINE;

ARTICLE; CONGENITAL TOXOPLASMOSIS; FIRST TRIMESTER PREGNANCY; HUMAN; INCIDENCE; MATERNAL DISEASE; PREGNANCY OUTCOME; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SENSITIVITY ANALYSIS; THIRD TRIMESTER PREGNANCY; VERTICAL TRANSMISSION; FEMALE; META ANALYSIS; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; RISK; TOXOPLASMOSIS; TRANSMISSION;

FEMALE; HUMANS; INCIDENCE; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY OUTCOME; RISK; TOXOPLASMOSIS;

EID: 84901376873     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097775     Document Type: Article

References (74)

1. Dubey JP (2010) Toxoplasmosis of Animals and Humans, Second Edition. Taylor & Francis.
2. Dubey JP (2009) History of the discovery of the life cycle of Toxoplasma gondii. Int J Parasitol 39:877-882.
3. Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965-1976. (Pubitemid 38759657)
4. Jones JL, Lopez A, Wilson M, Schulkin J, Gibbs R (2001) Congenital toxoplasmosis: a review. Obstet Gynecol Surv 56:296-305. (Pubitemid 32405839)
5. Olariu TR, Remington JS, McLeod R, Alam A, Montoya JG (2011) Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants. Pediatr Infect Dis J 30:1056-1061.
6. Bojar I, Szymanska J (2010) Environmental exposure of pregnant women to infection with Toxoplasma gondii-state of the art. Ann Agric Environ Med 17:209-214.
7. Torgerson PR, Mastroiacovo P (2013) The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ 91:501-508.
8. Desmonts G, Couvreur J (1974) Toxoplasmosis in pregnancy and its transmission to the fetus. Bull N Y Acad Med 50:146-159.
9. Robert Koch Institute (2007) Guideline toxoplasmosis. Epidemiol Bull 42:390-4.
10. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6): e1000097. doi:10.1371/journal.pmed1000097
11. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558. (Pubitemid 34746062)
12. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634. (Pubitemid 27387172)
13. Su CK, Wu ZB, Guo XB, Su PJ, Ma G (2002) The effects of toxoplasma infection on pregnancy in woman. Chinese journal of birth health & heredity 10:78-79.
14. Wen LZ, Liu LQ, Ao LM, Chen SH, Zeng WJ, et al. (2003) Effect of toxoplasma infection during pregnancy to the development of fetus and infant. Chin J Obstet Gynecol 38:331-333.
15. Liu J, Zhang L, Zhao XL, Ye GL, Cai XN, et al. (2004) Study on fetuses and infants' abnormalities induced by toxoplasmosis infection in pregnancy. Chinese journal of child health care 12:313-315.
16. Yan Q, Zhang HY (2006) The effects of toxoplasma infection during pregnancy on fetus. Modern Medicine & Health 22:1654-1655.
17. Yuan WY, Liu XH, Yu CY, Zhao S, Zhao Q, et al. (2009) Follow up and observation on effect of toxoplasma gondii infection during pregnancy on pregnant outcomes and live-born infants. Maternal & child health care of China 24:4416-4417.
18. Suo QL, Liu SW, Yao T (2011) Study of abnormal pregnancy outcome among toxoplasma IgM-positive pregnant women in Wuhan. Modern preventive medicine 38:863-865, 868.
19. Wang J, Yang JC, Ding XP (2011) The relation between toxoplasma infection and poor pregnancy outcomes in pregnant women. Journal of Shenyang Medical College 13:81-83.
20. Fang L, Li PL, Cui R (2012) An investigation on the influence of pregnant women infected with Toxoplasma gondii during the early pregnancy. Chinese journal of birth health & heredity 20:71,78.
21. Zhang Y, Li Y, Zhang XL, Shi KZ, Liu CJ, et al.(2002) Incidence of toxoplasmosis in 10114 generative women investigated and clinical trial. Journal of Tianjin Medical University 8:469-471.
22. Yang QF, Zhang H, Xiong P, Feng XF, Zhou YZ (2003) Serum epidemiological surveillance of TORCH infection in pregnant women in Zunyi. Chinese journal of Epidemiology 24:853.
23. Cao MG, Cao L (2004) Investigation and Analysis of Examination Result of Toxoplasma Gondii in 9638 Married Women at Reproductive Ages. Qilu journal of medical laboratory science 15:30-31.
24. Chen HM, Chai H, Le ZP, Liao HF (2004) Investigation of Toxoplasma infection in spontaneous abortion females. Journal of public health and preventive medicine 15:14-15, 19.
25. Hu CM, Yang X, Luo J (2004) Detection and analysis of the five infection indicators in pregnant women of North Guangdong. Practical Preventive Medicine 11:356-357.
26. Wei SZ, Lu SL, Xiao XH, Qi YY, Liu GH (2005) The investigation and analysis of TORCH infection in pregnant women of Ningde district. Chinese journal of birth health & heredity 13:108-109.
27. Yang AJ (2005) Detection of Toxoplasmosis infection in pregnant women. Practical Preventive Medicine 12:1434-1435.
28. Ye HZ, Gu SD, Huang CQ (2005) TORCH screenings in gestational period and outcomes of fetus from the pregnant women. Chinese primary health care 19:12-13.
29. Chen MR, Han YJ (2006) Investigation of infection rate of Cytomegalo Virus,Rubella Virus and Toxoplasma Gondii in married women at reproductive ages. Medcine Industry Information 3:34-35.
30. Li BY, Zhou P, Liu XY, Zhou LP, Zhou W (2006) Relationship between poor pregnancy outcome and TORCH infection in pregnant women. Maternal & Child health care of China 21:1628-1630.
31. Xie DC (2006) Analysis on the result of TORCH infection in 502 women with adverse pregnancy outcomes. Journal of Guangxi University of Chinese Medicine 9:42-43.
32. Chen XJ (2007) Study on toxoplasma infection among pregnant women in Changchun district. Journal of Changchun University of Traditional Chinese Medicine 23:92.
33. Guo EP, Zhang Z, Li JD, Wang SJ, Song MH (2008) Study on the relationship between TORCH infection and abnormal pregnancy in pregnant women. Modern Preventive Medicine 35:3823-3824.
34. Zhan HY (2008) Serum epidemiological surveillance of TORCH infection in pregnant women of Wuxi. Chinese journal of birth health & heredity 16:72.
35. Weng H, Chen J (2009) Analysis of the relationship between Toxoplasma IgM and women with adverse pregnancy outcomes in Ningbo. Chinese journal of birth health & heredity 17:78.
36. Long C, Fan W, Zhang JJ, Liu XZ (2011) Analysis on the relationship between TORCH infection and abnormal pregnancy. J Trop Med 11:1281-1282.
37. Qiu JZ, Zhou Y, Xu NW, Deng XB, Huang X (2011) Serological survey of Toxoplasma infection among pregnant women in Zhuzhou city. Chinese Journal of Clinical Rational Drug Use 04:100-101.
38. Wang JY (2011) Analysis of the specific TORCH antibody in pregnant women. Chinese Journal of Clinical Rational Drug Use 04:97-98.
39. Sarkar MD, Anuradha B, Sharma N, Roy RN (2012) Seropositivity of toxoplasmosis in antenatal women with bad obstetric history in a tertiary-care hospital of Andhra Pradesh, India. J Health Popul Nutr 30:87-92.
40. Wang KB, Zhang HW, Zhang J, Li XF (2012) Retrospective analysis of TORCH test in Bazhong area during 2009-2011. Laboratory Medicine and Clinic 9:1449-1452.
41. Moyo SR, Tswana SA, Nystrom L, Bergstrom S, Blomberg J, et al. (1995) Intrauterine death and infections during pregnancy. Int J Gynaecol Obstet 51:211-218.
42. Sahwi SY, Zaki MS, Haiba NY, Elsaid OK, Anwar MY, et al. (1995) Toxoplasmosis as a cause of repeated abortion. J Obstet Gynaecol (Tokyo 1995) 21:145-148.
43. Janak Kishore, Richa Misra, Abhiruchi Paisal, Yashodhra Pradeep (2011) Adverse reproductive outcome induced by Parvovirus B19 and TORCH infections in women with high-risk pregnancy. J Infect Dev Ctries 5(12):868-873.
44. Laila Nimri, Herve Pelloux,Layla Elkhatib (2004) Detection of Toxoplasma gondii DNA and specific antibodies in high-risk pregnant women. Am. J. Trop. Med. Hyg., 71(6), pp. 831-835
45. Wallon M, Peyron F, Cornu C, Vinault S, Abrahamowicz M, et al. (2013) Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis 56:1223-1231.
46. Mombro M, Perathoner C, Leone A, Buttafuoco V, Zotti C, et al. (2003) Congenital toxoplasmosis: assessment of risk to newborns in confirmed and uncertain maternal infection. Eur J Pediatr 162:703-706. (Pubitemid 37255503)
47. Naessens A, Jenum PA, Pollak A, Decoster A, Lappalainen M, et al. (1999) Diagnosis of congenital toxoplasmosis in the neonatal period: A multicenter evaluation. J Pediatr 135:714-719. (Pubitemid 30180420)
48. Hotop A, Hlobil H, Gross U (2012) Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy. Clin Infect Dis 54:1545-1552.
49. Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, et al. (1999) Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group. Lancet 353:1834-1837. (Pubitemid 29251015)
50. Pratlong F, Boulot P, Issert E, Msika M, et al. (1994) Fetal diagnosis of toxoplasmosis in 190 women infected during pregnancy. Prenat Diagn 14:191-198. (Pubitemid 24101557)
51. Gratzl R, Hayde M, Kohlhauser C, Hermon M, Burda G, et al. (1998) Follow-up of infants with congenital toxoplasmosis detected by polymerase chain reaction analysis of amniotic fluid. Eur J Clin Microbiol Infect Dis 17:853-858. (Pubitemid 29219152)
52. Dar FK, Alkarmi T, Uduman S, Abdulrazzaq Y, Grundsell H, et al. (1997) Gestational and neonatal toxoplasmosis: regional seroprevalence in the United Arab Emirates. Eur J Epidemiol 13:567-571. (Pubitemid 27306177)
53. Berrebi A, Assouline C, Bessieres MH, Lathiere M, et al. (2010) Long-term outcome of children with congenital toxoplasmosis. Am J Obstet Gynecol 203:551-552.
54. Hohlfeld P, Daffos F, Costa JM, Thulliez P, Forestier F, et al. (1994) Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med 331:695-699.
55. Ricci M, Pentimalli H, Thaller R, Rava L, Di Ciommo V (2003) Screening and prevention of congenital toxoplasmosis: an effectiveness study in a population with a high infection rate. J Matern Fetal Neonatal Med 14:398-403. (Pubitemid 38021689)
56. Berrebi A, Kobuch WE, Bessieres MH, Bloom MC, Rolland M, et al. (1994) Termination of pregnancy for maternal toxoplasmosis. Lancet 344:36-39. (Pubitemid 24199425)
57. Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, et al. (1999) Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 180:410-415. (Pubitemid 29093877)
58. Buffolano W, Beghetto E, Del PM, Spadoni A, Di Cristina M, et al.(2005) Use of recombinant antigens for early postnatal diagnosis of congenital toxoplasmosis. J Clin Microbiol 43:5916-5924. (Pubitemid 43100638)
59. Robert-Gangneux F, Gavinet MF, Ancelle T, Raymond J, Tourte-Schaefer C, et al. (1999) Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases. J Clin Microbiol 37:2893-2898. (Pubitemid 29391906)
60. Antsaklis A, Daskalakis G, Papantoniou N, Mentis A, Michalas S (2002) Prenatal diagnosis of congenital toxoplasmosis. Prenat Diagn 22:1107-1111. (Pubitemid 35448398)
61. Logar J, Petrovec M, Novak-Antolic Z, Premru-Srsen T, Cizman M, et al. (2002) Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant women. Scand J Infect Dis 34:201-204. (Pubitemid 34303060)
62. Gilbert R, Dunn D, Wallon M, Hayde M, Prusa A, et al. (2001) Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol. Epidemiol Infect 127:113-120. (Pubitemid 32825646)
63. Paola Di Carlo, Angela Mazzola, Amelia Romano, Maria Gabriella Schimmenti, Paola Colicchia, et al. (2005) Postnatal follow-up of infants born to mothers with certain Toxoplasma gondii infection: evaluation of prenatal management.Le Infezioni in Medicina, n. 2, 72-78.
64. Jenum A, Stray-Pedersen B, Melby KK, Kapperud G, Whitelaw A, et al. (1998) Incidence of Toxoplasma gondii Infection in 35,940 Pregnant Women in Norway and Pregnancy Outcome for Infected Women. J Clin Microbiol 36: 2900-2906 (Pubitemid 28429412)
65. Freeman K, Oakley L, Pollak A, Buffolano W, Petersen E, et al. (2005) Association between congenital toxoplasmosis and preterm birth, low birth-weight and small for gestational age birth. BJOG 112:31-37. (Pubitemid 40095077)
66. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, et al. (1999) Mother-tochild transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353:1829-1833. (Pubitemid 29251014)
67. Holliman RE: Congenital to xoplasmosis (1995) prevention, screening and treatment. J Hosp Infect 30 Suppl:179-190.
68. Desmonts G, Couvreur J (1974) Congenital toxoplasmosis. A prospective study of 378 pregnancies. N Engl J Med 290:1110-1116.
69. Xue CL (2000) Diagnosis, treatment and prevention of toxoplasma infection during pregnancy. Chinese journal of parasitology and parasitic diseases 18:55-57.
70. Wang SP, Yang XY, Jiang SH, Chen JP, Huang SG, et al. (2008) The immune characteristics of intrauterine vertical transmission of Toxoplasma gondii infection. Journal of Tropical Medicine 8:505-508.
71. Foulon W, Pinon JM, Stray-Pedersen B, Pollak A, Lappalainen M, et al. (1999) Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol 181:843-847. (Pubitemid 29503601)
72. Prusa AR, Kasper DC, Olischar M, Husslein P, Pollak A,et al. (2013) Evaluation of serological prenatal screening to detect Toxoplasma gondii infections in Austria. Neonatology 103:27-34.
73. Wallon M, Peyron F, Cornu C, Vinault S, Abrahamowicz M, et al. (2013) Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis 56:1223-1231.
74. Aljumaili ZKM, Alsamarai AM (2013) Risk factors for bad obstetric history in Kirkuk women, Iraq. Int J Infect Microbiol 2(3):70-77